trial · primary record
QTX-2101 + ATRA
Acute Promyelocytic Leukemia (APL)
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 150 |
| Primary completion | 2030-12 |
| Primary endpoint | Maximum observed plasma (concentration (Cmax) of QTX-2101 for ASIII |
| Registry ID | NCT07504458 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:28.433Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07504458
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.